Related Experiment Videos

DNA sequence specificity of mitoxantrone

C Panousis1, D R Phillips

  • 1Department of Biochemistry, La Trobe University, Bundoora, Victoria, Australia.

Nucleic Acids Research
|April 25, 1994
PubMed

Insights

Mitoxantrone preferentially binds to DNA at specific sequences, primarily 5'-(A/T)CA and 5'-(A/T)CG. This binding causes transcriptional blockages for E. coli RNA polymerase, revealing drug-DNA interaction patterns.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • Mitoxantrone is an anticancer agent.
  • Understanding drug-DNA interactions is crucial for drug development.

Purpose of the Study:

  • To determine the sequence specificity of mitoxantrone binding to DNA.
  • To investigate the impact of mitoxantrone binding on transcription.

Main Methods:

  • In vitro transcription assays using E. coli RNA polymerase.
  • Analysis of DNA fragments containing the lac UV5 promoter.

Main Results:

  • Transcriptional blockages predominantly occurred before 5'-CpA (64%) and 5'-CpG (29%) sequences.
  • 93% of blockages were before pyrimidine-purine sequences.
  • Preferred mitoxantrone intercalation sites are 5'-(A/T)CA and 5'-(A/T)CG, influenced by flanking A/T base pairs.

Conclusions:

  • Mitoxantrone exhibits sequence-specific DNA binding.
  • Binding occurs preferentially at 5'-(A/T)CA and 5'-(A/T)CG sites.
  • The location of blockages aligns with mitoxantrone's major groove interaction.

Related Concept Videos